Protein analysis Protoarray
Tuesday, 16 September, 2008
Invitrogen Corporation has launched the ProtoArray Human Protein Microarray v4.1 which enables customers to screen biological samples or labeled probe of interest against approximately 8,200 unique human proteins in as little as one day. This technology has a broad range of applications - identification of novel protein biomarkers specific for infectious diseases, cancers, and autoimmune diseases; mapping protein-protein interactions important to biochemical pathways; identification of kinase/ ubiquitin ligase substrates for target discovery and validation; antibody specificity profiling for research and therapeutic antibody development; and small molecule-protein radioligand profiling for drug candidate selection and development Invitrogen Tel: 1800 331 627 www.invitrogen.com/protoarray.
COVID-19 infection increases risk of heart attack and stroke
COVID-19 infection may increase the risk of heart attack, stroke and death from any cause for up...
A bout of COVID could protect you from a severe case of flu
Recovery from COVID appears to have a protective effect against the worst effects of the flu,...
Vaping bad for brain health; residue may affect unborn babies
University students who vape appear to have lower cognitive function scores, while exposure to...
